FRPH FRP HOLDINGS, INC. Insider Trading

Director John D Baker II purchased 478,468 shares of FRPH at $20.90 for $9,999,981.20 on 2026-03-23, raising stake to 3.05M shares (+18.6%).

Director Baker's $10.0M purchase represents a substantial 18.6% increase in his ownership stake at FRPH, a meaningful capital deployment. His prior trading history at this ticker shows 3 of 5 buys were well-timed on a 90-day basis, and his two most recent purchases (November 2025) each returned slightly positive over 90 days (+0.1% and +1.2%), though the stock has now declined 28.4% from its 52-week high and 13.3% over the past 30 days. The company's fundamentals show tight margins—annual revenue growth of +0.6% with a P/E of 86.33—making the timing and conviction behind a $10.0M accumulation noteworthy, though the subsequent 30-day price action diverges from the modest gains Baker achieved in his recent prior purchases.

Director Baker bought 854 FRPH shares at $23.85 on 2025-11-13; stock down 24.4% from 52-week high; cluster pattern with 2 other insiders buying within 14 days.

Director John D Baker II purchased 854 shares of FRP Holdings at $23.85, expanding his position to 199,879 shares, amid a broader cluster buy pattern with 2 other insiders trading within the past 14 days. The stock is currently down 24.4% from its 52-week high of $32.48 and has declined 1.5% over 30 days and 5.0% over 90 days. Notably, Baker's prior same-ticker transactions in May 2023 (three purchases) all resulted in significant 90-day losses (−45.9%, −48.1%, −47.5%), with a 0% win rate at the 90-day mark for those measurable outcomes. While the recent cluster activity suggests coordinated conviction, the company's elevated P/E of 102.29, modest annual revenue growth of +0.6%, and Baker's own poor timing track record at this ticker warrant investor attention.

Director John D Baker II bought 7,175 shares of FRPH at $23.85 on 2025-11-12 ($171.1K). Stock down 26.1% from 52-week high; prior FRPH buys underperformed.

Director Baker purchased 7,175 shares at $23.85, increasing his holdings to 199,025 shares. The purchase occurs while FRPH trades 26.1% below its 52-week high of $32.48, and comes as part of a cluster of insider buying activity—2 other insiders also acquired shares within the past 14 days. However, Baker's prior transaction history at FRPH raises caution: his 5 previous trades at this ticker (May 2023 and November 2025) show a 0% success rate when measured at the 90-day mark, with his three measured 2023 buys declining 45.8% to 47.8% over 90 days. The company's fundamentals remain modest: quarterly revenue of $10.8M, net income of $662.0K, and minimal annual growth of 0.6%, while the stock's P/E of 99.96 is elevated. The current price of $23.99 has already declined 2.8% in 30 days and 7.2% in 90 days, consistent with the broader downward trajectory.

CFO McNulty buys 2,000 shares at $23.84–$23.94; cluster of 3 insider purchases in 14 days signals coordinated interest amid -26.1% decline from 52-week high.

Matthew C. McNulty, CFO of FRPH HOLDINGS, INC., executed 2 separate purchases totaling 2,000 shares for $47,780.00 (blended average $23.89) on November 12–13, 2025. The stock has declined -26.1% from its 52-week high of $32.48 and -2.8% over the past 30 days, trading at $23.99 at filing. Notably, 2 other insiders also purchased within the past 14 days, forming a cluster buy pattern. McNulty's holdings increased 8.7% post-transaction to 25,106 shares. The company's fundamentals are challenged—annual revenue growth stands at +0.6% and the P/E ratio is 99.96—suggesting the market is pricing in limited near-term earnings expansion. The coordinated insider buying across three executives during a period of price weakness and structural valuation headwinds warrants investor attention to both the motivation underlying the cluster activity and the company's strategic direction.

Director Baker bought 334 FRPH shares at $23.50; prior same-ticker buys all underwater, 0 of 3 well-timed at 90 days.

Director John D Baker II purchased 334 shares at $23.50 on 2025-11-10, a modest addition increasing his stake by 0.2% to 191.8K shares. His prior three purchases at FRPH (May 2023) all declined sharply, with 90-day returns of -45.9%, -45.8%, and -47.8%; none were well-timed, meaning the stock fell further after each buy. His cross-ticker track record shows an average 90-day return of -9.5% and a 90d win rate of 63.64%. The stock is currently down 26.5% from its 52-week high and down 8.2% over 90 days. A cluster of 2 other insiders also bought within the past 14 days, though the company's fundamentals remain subdued—P/E of 99.46 and annual revenue growth of just +0.6%.

CEO Baker John D. III bought 4,166 shares of FRPH at $23.70; CEO cluster buy with 2 other insiders in past 14 days amid -26.5% YTD decline

CEO Baker John D. III purchased 4,166 shares at $23.70 on 2025-11-10, increasing his post-transaction holdings to 221,254 shares. This transaction is part of a cluster pattern: 2 other insiders also bought within the past 14 days. The timing occurs against a backdrop of significant price weakness—the stock trades at $23.87, representing -26.5% from its 52-week high of $32.48, and has declined -8.2% over the past 90 days. The company's fundamentals are modest: quarterly revenue of $10,775,000.00 with net income of $662,000.00, annual growth of only +0.6%, and a notably elevated P/E of 99.46. Multiple insiders purchasing at depressed levels warrants attention to whether management perceives material undervaluation or whether execution headwinds are temporary.

FRPH President & COO deVilliers bought 1,356 shares at $31.00; stock now at $28.76, down 11.4% from 52-week high.

deVilliers purchased 1,356 shares at $31.00 on 2025-03-05, increasing his holdings from 56,303 to 57,659 shares. The transaction occurred when FRPH was trading near its 52-week high of $32.48; the current price of $28.76 reflects a decline of 11.4% from that peak, with a 30-day decline of 7.9%. The company shows modest fundamentals: revenue of $10,633,000.00 for the latest quarter with net income of $1,361,000.00, coupled with very slow annual revenue growth of 0.6% and a notably elevated P/E of 63.91. The buy occurred at a price level the stock has since fallen below, and the absence of any disclosed trading flags or prior track record suggests this was an open-market transaction by a senior executive adding a 2.4% increment to an already substantial holding.